However, TROY is expressed once again in microglia in response to CNS-1 cells, suggesting this receptor plays a crucial role in microglial migration towards tumor cells, ultimately effecting glioma growth and invasion. The gene discussed is TNFRSF19; the disease is central nervous system cancer.